Results 131 to 140 of about 922,810 (288)

Real‐world insights on switching aflibercept dosage for enhanced outcomes in age‐related macular degeneration (RISE‐AMD): Safety data

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate real‐world safety experience with aflibercept 8 mg in a large case series of patients with neovascular age‐related macular degeneration (nAMD). Methods Due to a high proportion of patients on short treatment intervals, patients with nAMD at a Danish tertiary retina clinic were systematically switched to aflibercept 8 mg ...
Mary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, Mads Odgaard Mæng, Nanna Würtz Fabrin, Sigurrós Jónsdóttir, Anne Kjærsgaard Hassing, Søren Kveiborg Yde, Charles C. Wykoff, Henrik Vorum, Yousif Subhi, Marie Ørskov, Lasse Jørgensen Cehofski   +12 more
wiley   +1 more source

Real‐world incidence and clinical characteristics of intraocular inflammation following intravitreal faricimab therapy: A safety study

Acta Ophthalmologica, EarlyView.
Abstract Purpose To estimate the real‐world incidence of intraocular inflammation (IOI) following intravitreal faricimab injections at a large, highly specialized tertiary centre. Methods Single‐centre, retrospective cohort study with chart review using an electronic injection database and electronic medical records from November 2023 to August 2024 ...
Miklos Schneider, Leyla Turan, Farah Arif, Jakob Bjerager, Oliver Niels Klefter, Carsten Faber, Yousif Subhi, Javad Nouri Hajari   +7 more
wiley   +1 more source

Timing and duration of glucagon‐like peptide‐1 receptor agonist use and risk of nonarteritic anterior ischaemic optic neuropathy

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and nonarteritic anterior ischaemic optic neuropathy (NAION) in type 2 diabetes, examining treatment recency and cumulative duration. Methods This nationwide registry‐based nested case–control study utilizedz Danish health registries (1996 ...
Siar Niazi, Filip Gnesin, Baker Nawfal Jawad, Zia Niazi, Puriya Daniel Wuertz Yazdanfard, Anne P. Toft‐Petersen, Kathrine Kold Sørensen, Amani Meaidi, Yousif Subhi, Christian Torp‐Pedersen   +9 more
wiley   +1 more source

Relationships of Macular Functional Impairment With Structural and Vascular Changes According to Glaucoma Severity. [PDF]

Invest Ophthalmol Vis Sci, 2023
Hwang HS, Lee EJ, Kim H, Kim TW.
europepmc   +1 more source

Ocular Surface Disease and Dry Eye Severity in Glaucoma Patients at Urban Private Eye Care Centres in Malaysia [PDF]

Eng Hui Gan,1 Wen Wei Woo,1 Kheong Fang Seng,1 Pall Singh,2 Ming Yueh Lee,3 Vui Yin Kong,4 Say Peng Khoo,4 Mun Wai Lee,5 Liau Kok Liang6 1International Specialist Eye Centre, Kuala Lumpur, Selangor, Malaysia; 2Tun Hussein Onn National Eye Hospital ...
Lee MW, Singh P, Liang LK, Khoo SP, Seng KF, Kong VY, Woo WW, Gan EH, Lee MY   +8 more
core  

Vision‐related quality of life following trabeculectomy versus Baerveldt glaucoma implant: Five‐year results from a randomized clinical trial

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess the vision‐related quality of life (VRQoL) in glaucoma patients over 5 years after primary Baerveldt glaucoma implant (BGI) or trabeculectomy (TE) using a secondary analysis of a randomized clinical trial. Methods Patients were randomized to undergo TE or receive a BGI.
Ionela Popescu‐Giovanitsas, Jarinne E. Woudstra‐de Jong, Johannes R. Vingerling, Peter W. T. de Waard, Pieter W. M. Bonnemaijer   +4 more
wiley   +1 more source

Chlorhexidine 0.02% or polyhexamethylene biguanide 0.02% as the main treatment for Acanthamoeba keratitis

Acta Ophthalmologica, EarlyView.
Abstract Purpose To report medical cure and treatment failure rates of Acanthamoeba keratitis (AK) with respect to type of treatment, disease stage and prognostic factors. Methods Electronic records were reviewed for 45 patients with PCR‐positive AK treated at the Department of Ophthalmology, Aarhus University Hospital, Denmark from 2012 to 2025 ...
Anders Ivarsen, Sandra M. Skovdal, Stine Elkjær Nielsen, Christen Rune Stensvold, Henrik Vedel Nielsen, Jesper Hjortdal   +5 more
wiley   +1 more source

A three-tier AI solution for equitable glaucoma diagnosis across China’s hierarchical healthcare system

npj Digital Medicine
Artificial intelligence (AI) offers a solution to glaucoma care inequities driven by uneven resource distribution, but its real-world implementation remains limited.
Yi Zhou, Haitao Nie, Xinyu Gong, Minhui Dai, Zhaohong Guo, Xiaoling Deng, Mengyang Li, Yong Liu, Lingyu Sun, Xiangyi Tang, Ling Zhou, Zhiyao Tang, Ziqing Xia, Lemeng Feng, Wulong Zhang, Qingqing Yi, Xiaobo Xia, Bin Xie, Weitao Song   +18 more
doaj   +1 more source

Impact of the Affordable Care Act on Glaucoma Severity at First Presentation. [PDF]

Ophthalmic Epidemiol, 2023
Sekimitsu S, Elze T, Zebardast N.
europepmc   +1 more source

Advances in Glaucoma Treatment

Glaucoma is an optic neuropathy that is characterized by the death of retinal ganglion cells and leads to the progressive loss of vision. This Reprint presents the new frontiers in "Glaucoma Treatment".

core   +1 more source